GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS
<p>Glucocorticoids (GCs) are first-line drugs to treat systemic lupus erythematosus (SLE) of both high and moderate activities. These are the only agents that are able to provide so prompt anti-inflammatory and immunosuppressant effects in rheumatic diseases. Along with antimalarials and immun...
Main Authors: | N. V. Seredavkina, A. V. Smirnov, I. S. Dydykina, T. M. Reshetnyak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-11-01
|
Series: | Klinicist |
Subjects: | |
Online Access: | http://klinitsist.abvpress.ru/index.php/Klin/article/view/150 |
Similar Items
-
GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS
by: N. V. Seredavkina, et al.
Published: (2014-11-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients
by: Kaichi Kaneko, et al.
Published: (2021-10-01) -
Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
by: L A Archakova, et al.
Published: (2004-02-01)